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ABSTRACT
￿
In the accompanying paper (Bloom, G. S., T. A. Schoenfeld, and R. B. Vallee, 1983,
1. Cell Biol. 98:320-330), we reported that microtubule-associated protein 1 (MAP 1) from
brain comprises multiple protein species, and that the principal component, MAP 1A, can be
detected in both neuronal and glial cells by immunofluorescence microscopy using a mono-
clonal antibody. In the present study, we sought to determine the cellular and subcellular
distribution of MAP 1A in commonly used cultured cell systems. For this purpose we used
immunofluorescence microscopy and immunoblot analysis with anti-MAP 1A to examine 18
types of mammalian cell cultures. MAP 1A was detected in every culture system examined.
Included among these were cells of mouse, rat, Chinese hamster, Syrian hamster, Potoroo
(marsupial), and human origin derived from a broad variety of tissues and organs. Anti-MAP
1A consistently labeled mitotic spindles and stained cytoplasmic fibers during interphase in
most of the cultures. These fibers were identified as microtubules by co-localization with
tubulin in double-labeling experiments, by their disappearance in response to colchicine or
vinblastine, and by their reorganization in response to taxol . The anti-MAP 1A stained
microtubules in a punctate manner, raising the possibility that MAP lA is located along
microtubules at discrete foci that might represent sites of interaction between microtubules
and other organelles. Verification that MAP 1A was, indeed, the reactive material in immu-
nofluorescence microscopy was obtained from immunoblots. Anti-MAP 1A stained a band at
the position of MAP 1A in all cultures examined. These results establish that MAP 1A, a major
MAP from brain, is widely distributed among cultured mammalian cells both within and
outside of the nervous system .
Microtubules have been isolated from a variety of tissue and
cell sources, and have been found to be composed of tubulin
as well as a number ofassociated proteins (MAP).' MAP from
brain tissue have been most extensively characterized as a
result of the high yield of microtubule protein that can be
readily obtained from this source. In brain, the major MAP
appear on electrophoretic gelsas two groups ofhigh molecular
weight (HMW) polypeptides (270,000-350,000), known re-
spectively as MAP 1 and MAP 2 (41). The process ofdefining
these proteins is not yet complete, as indicated by evidence
presented in the accompanying paper (3) that MAP 1 consists
of several biochemically distinct proteins. In addition to the
'Abbreviations used in this paper.
￿
HMW, high molecular weight;
MAP, microtubule-associated protein.
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HMW MAP, several less prominent MAP that are associated
with MAP 1 and MAP 2 have been found in brain microtu-
bule preparations. These include Mr 28,000 and 30,000 light
chains of MAP 1 (49), and a type II cAMP-dependent protein
kinase, as well as an Mr 70,000 protein associated with MAP
2 (42, 46). In addition, a group of MAP known collectively
as tau (Mr 55,000-62,000) are prominent in brain microtu-
bule preparations (7, 52).
A number of investigations have been conducted to deter-
mine whether the MAP found in brain tissue are present in
cultured cells. The results ofthese studies have been somewhat
contradictory. Microtubules have been isolated and exten-
sively purified from HeLa cells and Neuro-2a neuroblastoma
cells (5, 32, 50). Polypeptides found to co-purify to constant
stoichiometry with tubulin include HeLa cell peptides of
331210,000 and -125,000 mol wt (5, 50), and Neuro-2a cell
peptides of 215,000 and 71,000 mol wt (32). HMW MAP
corresponding to the brain proteins MAP 1 and MAP 2 were
not detected in these purified microtubules or in partially
purified microtubules from other cell lines(12, 30, 34). Sim-
ilarly, Duerr et al. (13) found no evidence for MAP 1 or MAP
2 in a wide variety ofcell lines using a procedure designed to
extract microtubule proteins selectively from cells.
In contrast to these studies were the results of immunoflu-
orescence microscopy using antibodies to unfractionated
HMW MAP from brain tissue (8, 37-39). These antibody
preparations reactedwith microtubules in a variety ofcultured
cells, suggesting that some component of the HMW brain
MAP was, indeed, present in many cell types. Immunoreac-
tivity was observed both on interphase and mitotic microtu-
bules. In support of a more general distribution for the HMW
MAP, there have been two reports that SV40-3T3 cells con-
tain a HMW polypeptide that co-purifies with carrier brain
microtubules (7, 25). More recently, Weatherbee et al. (51)
identified MAP 2 in purified HeLa cell microtubules with the
use ofa monoclonal antibody. However, the amount ofMAP
2 was very low relative to the other MAP in HeLa cells, and
therefore,the functional significance ofthe HeLa MAP 2 was
questioned. MAP 2 has been found in some other cells, but
could not be detected in most cell linesexamined (23, 26, 33,
43). MAP 2 was also undetectable in non-neuronal cells in
sections of brain and spinal cord (11, 29) further supporting
the notion that this protein either does not occur universally
in cells or is present at very low levels in non-neuronal cells.
This suggests that some component ofthe MAP 1 complex
of HMW polypeptides (3) was detected in those earlier studies
that had indicated a widespread occurrence of HMW MAP.
One recent study of differentiated PC12 cells identified a
polypeptide (termed MAP 1.2) that was in the molecular
weight range of MAP 1, and was determined to be a MAP by
a combination ofmicrotubule purification and antibody tech-
niques (17). Hill et al. (20a) and Sherline and Moscardo (36a)
used polyclonal antibodies to brain MAP 1 to stain cultured
cells. The antibodies stained a variety ofstructures in addition
to microtubules, and the precise identities of the immuno-
reactive proteins were not reported. Aside from those studies
and our preliminary identification of MAP 1 in pituitary
tissue and cells (47), the distribution of MAP 1 and of the
individual polypeptide components of MAP 1 has not been
explored.
In addition to the question of its distribution, MAP 1 has
been less extensively characterized than MAP 2 with regard
to its biochemical properties. Much of the MAP 1 in micro-
tubule preparations can be associated with MAP 2 (49),
making an evaluation of its properties difficult. Purified MAP
1 did bind to microtubules in a periodic fashion, indicating a
specific binding site for MAP 1 on the microtubule surface
(49). However, no direct evidence for an association of MAP
1 with microtubules in cells has been presented.
In the accompanying study (3), we used a monoclonal
antibody to MAP 1 A, our designation for the major polypep-
tide in the MAP 1 region on SDS gels, to determine the
distribution ofthis protein in nervous system tissue and cells.
We found that, unlike MAP 2, which was largely restricted to
the somata and dendritic processes of neuronal cells, MAP
1 A was present in axons and glial cells as well. Along with
earlier biochemical work comparing the content of MAP 1
and MAP 2 in microtubules from bovine gray and white
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matter (44), these results indicated that MAP 1 was, indeed,
more widely distributed than MAP 2. In the study described
here, we have extended this investigation to a broad spectrum
of cultured cell types. We found that MAP IA is distributed
almost universally among cultured mammalian cells, and is
particularly prominent in the mitotic spindle of cells undergo-
ing division. It was found in association with cytoplasmic
fibers that co-labeled with antitubulin. This indicates that
MAP lA is, indeed, a MAP, and one that is associated with
microtubules under a wide range of conditions.
MATERIALS AND METHODS
Cell Cultures:
￿
All cell lines and strains were maintained in a 37°C
incubator (5%C02, 95% air) in 60-mm petri dishes (Falcon Labware, Becton,
Dickinson & Co., Oxnard, CA). For immunofluorescence microscopy cells
were grown on glass coverslips coated with poly-L-lysine or fetal calf serum.
Media components were from Gibco Laboratories (Grand Island Biological
Co., Grand Island, NY), and all media contained pen/strep. Mostcultures were
maintained in Dulbecco's MEM, 10% fetal calfserum. Exceptions were RIN-
5F (obtained from Dr. Herbert K. Oie, National Cancer Institute)(RPMI 1640,
10% fetal calfserum), PC 12 (Dulbecco's MEM, 10% each fetal calfand horse
serum), and B104 (43% each F-12 and Dulbecco's MEM, 8% horse serum, 5%
fetal calf serum).
Primary cell cultures from newborn rat lung, heart, kidney, and skeletal
muscle tissue were prepared as follows. Freshly dissected tissue was minced
with a scalpel and trypsinized for 15 min at 37°C. After brief centrifugation,
the single cells and small clumps of tissue were resuspended in the medium
used for B104 cells, and plated into 60-mm petri dishes (Falcon Labware)
coated with 0.5% gelatin. The cultures were placed in the 37°C incubator for
30 min to permit most fibroblasts to attach. The unattached cells were then
replated into new dishes containing gelatin-coated coverslips, and returned to
the incubator. These more slowly attaching cellswere used forthe experiments.
Primary cultures of newborn rat brain were prepared as we have described (2).
Immunocytochemistry and Immunochemistry: Single and
double immunofluorescence microscopy of cultured cells were performed as
described in the preceding paper (3). The primary antibodies were monoclonal
mouse anti-MAP IA (3) and polyclonal goat antitubulin (kindly provided by
Dr. Robert Weihing, WorcesterFoundation for Experimental Biology). Second
antibodies were IgG fractions ofsheep anti-mouse IgGandsheep anti-goat IgG,
labeled respectively with rhodamine and fluorescein. These conjugates were
prepared in our laboratory from crudeantisera (Cappel Laboratories, Cochran-
ville, PA)according to the method of Forni (15).
Immunoblot analysis (2, 3) was performed with anti-MAP IA antibody
obtained from ascites fluid. Sampleswere prepared by dissolvingthe cells from
each confluent 60-mm petri dish in 200,u1 ofSDSsample buffer. 50,u1 ofeach
sample was used for the immunoblots.
RESULTS
Subcellular Localization of MAP IA in Mitotic,
Interphase and Drug-treated Cells
To determine the intracellular structures that were immu-
noreactive with anti-MAP IA, we used immunofluorescence
microscopy. For these experiments we examined several va-
rieties of cell lines, strains, and primary cultures. The most
striking and consistent result of these experiments was the
staining of mitotic spindles and spindle remnants in dividing
or recently divided cellsby anti-MAP IA. We observed stain-
ing in representative spindles from all cultured cell systems
examined, except CHO-K1 (see Table I). Examples of MAP
IA localization in mitotic spindles from 12 cultured cell
systems are illustrated in Fig. 1 .
During interphase, the pattern and intensity of staining by
anti-MAP 1A was variable. Staining patterns ranged from
diffuse cytoplasmic fluorescence to bright punctate staining
of cytoplasmic fibers. Staining of fibers varied in intensity
from cell type to cell type, but was observed in most cells
examined (Table I). To verify that the cytoplasmic fibersKey to symbols: -, neverobserved; +, rare cells or weak fluorescence; ++, many cells, moderate fluorescence; +++, most cells, moderate-strongfluorescence.
* MAP lA apparently present in beating cardiac muscle cells.
MAP1A present in fused myotubes and in mononucleate cells.
MAP 1A found in neurons, oligodendrocytes and astrocytes (see accompanying paper [31).
stained by anti-MAP IA corresponded to microtubules, we
performed double labeling experiments with antibodies to
MAP 1 A and tubulin. Fig. 2 shows primary rat brain cells,
mouse neuroblastomas (clones Neuro-2a and NIE-115), hu-
man fibroblasts (WI-38), and rat glioma cells (C6) stained in
this manner. It is readily apparent that fibers stained almost
continuously with antitubulin were also stained discontin-
uously by anti-MAP IA. We noted that staining by anti-MAP
IA was punctate in all cell types in which MAP lA was
observed on cytoplasmic fibers. We used a variety of fixation
protocols to evaluate their effect on the pattern of MAP 1 A
immunofluorescence. These included fixation and permea-
bilization with absolute methanol at -20°C alone or in com-
bination with glutaraldehyde, or fixation ofdetergent-resistant
cytoskeletons with either methanol or glutaraldehyde. All
methods resulted in punctate staining of microtubules indis-
tinguishable from those observed in cells permeabilized with
methanol, the procedure used for all figures in this paper.
In a recent study (2), we used vinblastine and colchicine
treated cells to identify cellular binding sites other than mi-
crotubules for MAP 2, the most prominent high molecular
weight brain MAP. In the present study, we similarly used
drugs that depolymerize or stabilize microtubules to examine
the fate of MAP lA when the normal distribution of tubulin
is disrupted. In colchicine-treated (not shown) or vinblastine-
treated cells (Fig. 3), fibrous staining by anti-MAP lA was
abolished, consistent with a normal association of MAP lA
with microtubules. Fluorescence was still punctate, with spots
of various sizes being distributed randomly throughout the
cytoplasm. Comparison of immunofluorescent (Figure 3, a,
c, and e) and phase-contrast (Fig. 3, b, d, and .f) images for
TABLE I
Distribution of MAP 1A in Cultured Cells
three cell types treated with 10 uM vinblastine for 18 h
illustrates that neither tubulin paracrystals nor intermediate
filament bundles were specifically stained by anti-MAP IA.
While anti-MAP 2 also failed to stain vinblastine-induced
tubulin paracrystals, it did stain intermediate filament bundles
in cells treated with vinblastine or colchicine (2). Therefore,
MAP IA and MAP 2 differ dramatically in their ability to
bind to intermediate filaments.
Another drug that alters microtubules is taxol. This com-
pound induces the reorganization of microtubules from a
radial distribution emanating from organizing centers near
the nucleus, to a randomly distributed system of fascicles,
which originate at multiple organizing sites scattered through-
out the cytoplasm (10, 35). To test whether the distribution
of MAP 1 A could be similarly altered by taxol, we exposed
cellsto 10 uM taxol for 18 h before staining them with anti-
MAP IA. Fig. 4 shows examples from a variety of cultured
cells of typical taxol-induced bundles of cytoplasmic fibers
that were stained by anti-MAP IA. Double-labeling of pri-
mary rat brain cells with anti-MAP IA (Fig. 4j) and antitu-
bulin (Fig. 4 k) demonstrated that the fiberbundles stained by
anti-MAP lA were, indeed, co-localized with microtubules.
While most staining patterns observed in interphase cells
were consistent with localization ofMAP 1 A on microtubules,
one additional pattern of staining was occasionally seen.
Numerous patches of fluorescence 1-2 /m across were ob-
served on the surface ofthe nucleus in rare cells(Fig. 5). More
commonly we observed cells with smaller numbers (typically
1-3) of larger nuclear spots, examples of which may be seen
elsewhere in this paper(see Fig. 2, c, e, and i).
None of the staining properties we have described for anti-
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Species Cell type
Immunofluorescence Microscopy
Interphase Mitosis
Labeled Micro- Labeled
by anti- tubules by anti- Spindle
MAP 1A? visible? MAP 1A? visible? Immunoblot: MAP lA labeled?
Mouse 3T3; fibroblast + Yes ++ Yes Yes
Neuro-2a; neuroblastoma +++ Yes +++ Yes Yes
11 N1E-115 neuroblastoma +++ Yes +++ Yes Yes
Rat RIN-5F; pancreatic islet tumor +++ Yes +++ Yes Yes
C6; glioma +++ Yes +++ Yes Yes
13104; neuroblastoma + Yes ++ Yes Yes
PC12; pheochromocytoma +++ No +++ Yes Yes
Primary newborn lung + Yes ++ Yes Not tested
Primary newborn heart` ++ Yes +++ Yes Not tested
Primary newborn skeletal mus- + No ++ Yes Not tested
cle*
Primary newborn kidney + Yes ++ Yes Not tested
Primary newborn brains +++ Yes +++ Yes Yes
Chinese hamster CHO-K1 ; ovary + No + No Yes; plus lower molecular weight
bands
Syrian hamster BHK-21 ; kidney ++ Yes ++ Yes Yes; plus lower molecular weight
bands
Potoroo PtK1 ; kidney - No ++ Yes Not tested
Human WI-38; lung fibroblast +++ Yes +++ Yes Yes
" HeLa; cervical carcinoma + No + Yes Yes
11 MG-63; osteosarcoma + Yes + Yes Not testedFIGURE 1
￿
Localization of MAP 1A in dividing cells . Anti-MAP 1A consistently labeled mitotic spindles and spindle remnants in
numerous types of cultured cells . (a) WI-38, human lung fibroblast . (b) BHK-21, baby hamster kidney . (c) Primary newborn rat
lung . (d) Primary newborn rat kidney . (e) 3T3, mouse fibroblast . (f) RIN-5F, rat insulin-secreting pancreatic islet tumor. (g) Primary
newborn rat skeletal muscle . (h) PtK1, marsupial (Potoroo) kidney . (i) Neuro-2a, mouse neuroblastoma . (i) C6, rat glioma . (k)
Primary newborn rat heart . (I) HeLa, human cervical carcinoma . Bar, 10wm . x 1,500 .
MAP IA were observed in a variety of immunofluorescent
control experiments (not shown) . No staining was observed
when anti-MAP lA was replaced by unconditioned medium,
or by sea urchin-specific monoclonal antibodies (48) present
in conditioned medium or ascites fluid. Preadsorption ofanti-
MAP 1A with excess MAP 1A present in a brain MAP
preparation (45) abolished all cytoplasmic staining. However,
punctate staining of the outer surface of the nucleus was
markedly enhanced with the adsorbed antibody .
Immunochemical Identification ofMAP IA in
Cultured Cells
The immunofluorescence results described to this point
prove that material cross-reactive with anti-MAP 1A is widely
distributed among mammalian cells . To verify that MAP lA
was, indeed, the immunoreactive species, we used immuno-
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blot analysis . Cultured cells were washed thoroughly in PBS
and dissolved directly in hot SDS gel sample buffer. After
SDS PAGE, nitrocellulose replicas of the gels were prepared
and stained with anti-MAP IA . A protein with the electro-
phoretic mobility of MAP IA was generally detected (see
Table 1) and examples from ten different cultured cell systems
are shown in Fig. 6 . The species and cell types represented
here are diverse and include mouse (3T3 fibroblast, Neuro-
2a, and N 1E-115 neuroblastomas), rat (C6 glioma, B104
neuroblastoma, PC12 pheochromocytoma, and RIN-5F in-
sulin-secreting, pancreatic islet tumor cells [31]), Chinese
hamster (CHO-K1 ovary cells), Syrian hamster (BHK-21 kid-
ney cells), and human (WI-38 lung fibroblasts) . In many of
the cells tested, faintly staining bands with lower molecular
weights than MAP 1A could also be detected, and these
presumably represented proteolytic fragments ofMAP IA. In
two cases, CHO-K1 and BHK-21, we detected prominentFIGURE 2
￿
Co-localization of MAP 1A and tubulin in nondividing cells . Double-labeling was performed with monoclonal anti-
MAP 1A (a, c, e, g, and i) and goat antitubulin (b, d, f, h, and j) followed by rhodamine sheep anti-mouse IgG and fluorescein
sheep anti-goat IgG . (a and b) N 1 E-115, mouse neuroblastoma . These figures illustrate a small portion of the cytoplasm in a giant,
multinucleate cell . (c and d) WI-38, human fibroblast . (e and f) Neuro-2a, mouse neuroblastoma . (g and h) Primary newborn rat
brain cell, most likely an astrocyte. (i and j) C6, rat glioma . Bars : 10 Am (in a, for a and b ; in c for all others) . (a and b) x 1,500 .
(c-j) x 600 .
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￿
Localization of MAP 1A in vinblastine-treated cells . Cells were treated with 10 AM vinblastine sulfate for 18 h before
being stained with anti-MAP-1A . Corresponding immunofluorescence (a, c, and e) and phase-contrast (b, d, and f) micrographs
are shown . (a and b) WI-38 ; human fibroblast . (c and d) Neuro-2a; mouse neuroblastoma . (e and f) N1 E-115 ; mouse neuroblastoma .
The arrows (b, d, and f) point to vinblastine-induced tubulin paracrystals, several of which are found in each cell . Bar, 10 Am . x
650 .
bands of slightly greater electrophoretic mobility than MAP
IA . These may have represented large fragments ofMAP IA .
We estimate that we detected between 1 and 10 ng MAP lA
per sample, and that the samples varied from -10 to 60 gg
protein. These figures permit us to estimate that MAP IA
commonly constitutes from 0.01% to 0.04% of the total
protein in cultured cells.
DISCUSSION
In the accompanying paper (3), we demonstrated that MAP
1, a prominentHMW component ofpurified brain microtu-
bules, comprises multiple protein species . The most abundant
of these, which we call MAP 1 A, was uniquely recognized by
a monoclonal antibody which we produced . Immunofluores-
cence microscopy performed with this antibody indicated that
MAP 1A was distributed widely in the nervous system, being
present in several types of neuronal and glial cells in vivo,
and in primary brain cell cultures . In the present communi-
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cation we have demonstrated the presence of MAP 1A by
immunoblot analysis and immunofluorescence microscopy
in numerous cultured mammalian cell types derived from a
broad variety of tissues . The intracellular structures stained
most conspicuously by anti-MAP 1A were mitotic spindle
microtubules, which were seen in most cell types examined.
In interphase cells the antibody stained cytoplasmic fibers
identified as microtubules by co-localization with tubulin,
and their response to colchicine, vinblastine and taxol . Al-
though staining in interphase cells was generally limited to
the cytoplasm, we occasionally observed immunoreactive
spots on the surface of the nucleus . A summary of our
immunocytochemical and immunochemical analysis ofMAP
lA in 18 cultured cell systems is shown in Table I .
Cellular Distribution of MAP 1A
A variety of approaches have been used to identify the
MAP in cultured cells . Biochemical approacheshave generallyfailed to detect appreciable quantities of any of the HMW
MAP, i.e ., MAP 1 and MAP 2, first described in purified
brain microtubules (5, 12, 13, 30, 32, 50) . Two notable
exceptions are the recent discoveries of MAP 1-like proteins
in PC12 cells treated with nerve growth factor (17), and in
pituitary tissue and cells (47) . The PC 12 cell protein identified
in the earlier study was evidently not MAP IA . However,
because our anti-MAP 1A reacted with PC 12 cells grown in
the presence or absence of nerve growth factor on immuno-
blots and by immunofluorescence microscopy (see lane 7 in
Fig . 6 for an immunoblot ofuntreatedPC12 cells) . Therefore,
PC 12 cellsmay contain more than one type ofMAP 1 protein .
immunological studies have consistently indicated that ma-
terial cross-reactive withHMW brain MAP is, indeed, found
commonly in cultured cells (8, 37-39) . The precise identity
ofthe immunoreactive material observed in these studies was
not known, though, because the antibodies employed were
directed against unfractionated HMW brain MAP, which
include several distinct protein species .
Our finding that monoclonal anti-MAP 1A commonly
FIGURE 4
￿
Distribution of MAP 1A in taxol-treated cells. Cultures were treated with 10 pM taxol for 18 h before being labeled
with anti-MAP 1A, alone (a-i) or in combination with antitubulin (j and k) . (a) N1E-115, mouse neuroblastoma . (b) 3T3, mouse
fibroblast . (c) WI-38, human fibroblast . (d) B104, rat neuroblastoma . (e) BHK-21, baby hamster kidney. (f) HeLa, human cervical
carcinoma. (g) C6, rat glioma . (h) RIN-5F, rat insulin-secreting pancreatic islet tumor . (i) Neuro-2a, mouse neuroblastoma . (j and
k) Primary newborn rat brain cells labeled with monoclonal anti-MAP to (j) and goat antitubulin (k) followed by rhodamine sheep
anti-mouse IgG and fluorescein sheep anti-goat IgG . Bars : 10,um (in a, for a, c, d, e, j, and k; in b, for b, f, g, h, and i) . (a, c, d, e,
j, and k) x500. (b, f, g, h, and i)x825 .
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337FIGURE 5 Immunoreactivity of the surface of the nucleus with
anti-MAP 1A . The nucleus of a HeLa cell stained with anti-MAP 1A
is shown . Bar, 10 Am . x 1,300.
FIGURE 6
￿
Immunochemical detection ofMAP to in cultured cells .
An immunoblot is shown . Cells were dissolved directly in sample
buffer, and subjected to SDS PAGE . A nitrocellulose replica of the
gel was then stained with anti-MAP 1A followed by peroxidase-
sheep anti-mouse IgG, for which 4-chloro-l-naphthol was used as
a substrate . Lanes: (1) WI-38, human fibroblast. (2) N1 E-115, mouse
neuroblastoma . (3) Neuro-2a, mouse neuroblastoma . (4) 3T3,
mouse fibroblast . (5) B104, rat neuroblastoma . (6) RIN-5F, rat insu-
lin-secreting pancreatic islet tumor . (7) PC12, rat pheochromocy-
toma . (8) C6, rat glioma . (9) CHO-K1, Chinese hamster ovary . (10)
BHK-21, baby hamster kidney . Arrow at left indicates position of
MAP IA .
stained interphase and mitotic spindle microtubules in cul-
turedmammalian cells derived from numerous tissue sources
may explain, at least in part, the earlier immunocytochemical
studies using polyclonal antisera of unknown specificities .
Immunoblots of the cells we examined suggested that MAP
lA commonly constitutes from 0.01-0.04% of total cellular
protein, a range only slightly below that reported for a major
HeLa cell MAP of 210,000 mol wt (6), raising the question
of why this protein has not been detected biochemically in
microtubule protein preparations obtained from 3T3, Neuro-
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2a, C6, PC 12, CHO-K 1, BHK-21, and HeLa cells (5, 13, 17,
30, 32, 50) .
Several considerations may explain whyHMW MAP have
generally not been detected in cultured cells by biochemical
means . First, all of the HMW brain MAP, except MAP 1C,
are extremely sensitive to proteases (see, for example, Fig . 1 C
in the accompanying paper) . Therefore,HMW MAP present
in intact cells may be degraded by exposure to cellular pro-
teases during the preparation of microtubule proteins for
electrophoretic analysis. We attempted to avoid this potential
problem for the study presented here by identifyingMAP 1A
on immunoblots ofcells dissolved directly in hot SDS sample
buffer, in which proteolysis was likely to be minimal . Despite
our efforts, appreciable fragmentation ofMAP lA may have
occurred in samples of CHO-K1 and BHK-21 cells (see Fig .
6, lanes 9 and 10), underscoring the sensitivity of this protein
to proteolysis. Another possible explanation is that HMW
MAP may associate not only with microtubules, but with
other subcellular structures as well. In fact, we have recently
presented evidence that MAP 2 associates with intermediate
filaments, as well as with microtubules in cultured brain cells
(2) . In the present study we noted residual anti-MAP 1A
immunoreactivity associated with punctate cytoplasmic struc-
tures after vinblastine or colchicine treatment, suggesting that
MAP IA may remain bound to particulate structures after
dissolution of microtubules (see below) . Finally, at least in
some cells, MAP IA appears to be most striking in mitotic
spindle microtubules. This suggests that the concentration of
this protein could be cell cycle-dependent, and could be low
in unsynchronized cultures.
Subcellular Distribution ofMAP 1A
MAP IA has been previously identified as a MAP on the
basis of its co-purification with microtubules in vitro . Until
now, no evidence had been presented indicating that this
association occurs in the cell as well . As we have shown in
Fig . 1, anti-MAP lA stained the spindle in a manner consist-
ent with the localization ofMAP lA on microtubules during
mitosis. In addition, anti-MAP IA stained cytoplasmic fibers
in interphase cells, and identification of these fibers as micro-
tubules was determined by three lines of evidence . First, the
fibers colocalized in double-labeling experiments with tubulin
(see Fig. 2). Next, treatment of cells with anti-microtubule
drugs, such as colchicine or vinblastine, abolished the fibrillar
distribution of MAP IA (see Fig. 3) . It is noteworthy that
MAP IA was not detected in these experiments on interme-
diate filament cables, as we have reported for MAP 2 (2), nor
in vinblastine-induced tubulin paracrystals, as has been ob-
served for the HeLa cell 210,000-mol-wt MAP (9) . Finally,
treatment of cells with taxol (see Fig . 4) induced the reorga-
nization of fibers stained by anti-MAP IA into bundles co-
distributed with those stained by antitubulin .
Although antibodies to both MAP IA and tubulin stained
cytoplasmic microtubules in interphase cells, the staining was
qualitatively different for the two antibodies . Antitubulin
produced nearly continuous staining of microtubules in cells
fixed and permeabilized by a wide variety ofprocedures, while
anti-MAP lA stained the microtubules in a punctatemanner.
It is not clear whether this represents the true distribution of
MAP lA or a fixation artifact . Though we cannot eliminate
the latter possibility, we favor the former hypothesis because
ofthe highly reproducible appearance ofthe punctate pattern
observed in numerous cell types fixed and permeabilized byseveral protocols. In addition, the punctate appearance of
MAP 1A persisted even when the normal microtubule distri-
bution was disrupted by colchicine or vinblastine (see Fig. 3).
This suggests that MAP 1A is normally associated with dis-
crete structures along microtubules and that these structures
can persist when microtubules are depolymerized. Further
work is needed to test this supposition, and to identify what
structures, if any, are co-distributed with MAP IA along
microtubules (see further discussion below).
An additional pattern of nonmicrotubular staining was also
occasionally observed. Spots of fluorescence were seen on the
surface of the nucleus by optically sectioning cells with high
magnification objectives (see Fig. 5). This result is reminiscent
of a staining pattern observed with an antibody to ankyrin, a
protein related immunologically to MAP 1 (1). Our anti-MAP
IA antibody did not cross-react with rat or sheep ankyrin
(not shown), however, suggesting that MAP lA may, indeed,
have a binding site on the surface of the nucleus. In support
of this possibility we noticed that anti-MAP IA could be
induced to stain a far greater number of nuclear spots than
we normally saw by preadsorbing the antibody with a molar
excess of MAP IA present in a MAP preparation (45) from
calf brain. Presumably, the antibody was binding indirectly
to the nucleus via MAP lA molecules, whose nuclear binding
site was undisturbed by bound antibody, and for which most
nuclearbinding siteswere unoccupied in fixed cells. It remains
to be determined what functions, may be attributed to MAP
lA localized at discrete foci on the surface of the nucleus.
Function of MAP 1A
In view of the evidence presented here, we propose that one
role for MAP IA is in mitosis. Electron microscopic studies
have indicated the existence of cross-bridges connecting mi-
crotubules to one another in mitotic spindles (4, 22, 27, 53),
and these cross-bridges have been proposed to be involved in
organizing spindle microtubules and in generating the force
that drives chromosome movement (28). We have recently
purified MAP 1 and found that it has the appearance of fine
periodic arms on the surface of the microtubule (49). Thus,
MAP IA could be a component of the microtubule cross-
bridges that have been observed in mitotic spindles.
The discontinuous, punctate staining by anti-MAP IA of
microtubules in interphase cells suggests an alternative hy-
pothesis. Ultrastructural studies have consistently supported
the idea that individual microtubules can be connected in
cellsto vesicles, granules, and other membrane-bound organ-
elles (14, 21, 36), and may also be involved in the transport
of these structures (16, 19). Further work will be needed to
determine whether the discontinuous anti-MAP IA fluores-
cence that we regularly observed corresponds to recognizable
cellular organelles, thereby implying that MAP 1A linksthose
structures to microtubules. If this turns out to be true, it will
raise the further question of how this function of MAP 1A
relates to the localization of this protein in neuronal and glial
processes in the nervous system. Certainly particle transport
is known to occur actively in neuronal processes, and an
involvement ofMAP 1A in the transport ofmyelin precursors
seems reasonable as well. Perhaps MAP IA is also involved
in mediating the interaction of vesicles with microtubules
within the mitotic spindle. The interaction of microtubules
and vesicles has been repeatedly observed by electron micros-
copy (18, 20, 40) and has been proposed to account for
localized regulation of calcium concentrations in the spindle
(24, 40, 54). Whether this hypothesis is correct or not, it seems
clear that MAP lA will prove to be involved in more general
functions of microtubules than MAP 2.
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